Observed (Obs) and expected (Exp) number of cancers, standardised incidence ratios (SIRs) for selected cancers adjusted for age and period, and 95% CI among 2663 Navy submariners for the follow-up period 1953–2021 (110 064 person-years)
| Cancer site | ICD-10 | Obs | Exp | SIR | 95% CI |
| All sites | C00–96 | 782 | 681.30 | 1.15 | 1.07 to 1.23 |
| Stomach | C16 | 17 | 15.44 | 1.10 | 0.64 to 1.76 |
| Small intestine | C17 | 3 | 3.64 | 0.82 | 0.17 to 2.41 |
| Colon | C18 | 68 | 52.39 | 1.30 | 1.01 to 1.65 |
| Rectum, rectosigmoid | C19–20 | 33 | 32.61 | 1.01 | 0.70 to 1.42 |
| Pancreas | C25 | 12 | 16.63 | 0.72 | 0.37 to 1.26 |
| Lung, trachea | C33–34 | 84 | 72.54 | 1.16 | 0.92 to 1.43 |
| Melanoma | C43 | 61 | 39.02 | 1.56 | 1.20 to 2.01 |
| Skin, non-melanoma | C44 | 61 | 35.02 | 1.74 | 1.33 to 2.24 |
| Mesothelioma | C45 | 5 | 3.05 | 1.64 | 0.53 to 3.82 |
| Soft tissues | C48–49 | 8 | 3.00 | 2.66 | 1.15 to 5.25 |
| Prostate | C61 | 176 | 179.42 | 0.98 | 0.84 to 1.14 |
| Testis | C62 | 10 | 12.34 | 0.81 | 0.39 to 1.49 |
| Kidney excluding renal pelvis | C64 | 21 | 21.21 | 0.99 | 0.61 to 1.51 |
| Bladder, renal pelvis and other urinary organs | C65–68 | 62 | 46.16 | 1.34 | 1.03 to 1.72 |
| Brain, nervous system | C70–72 | 21 | 20.69 | 1.02 | 0.63 to 1.55 |
| Hodgkin lymphoma | C81 | 8 | 3.72 | 2.15 | 0.93 to 4.24 |
| Non-Hodgkin's lymphoma | C82–86, C96 | 27 | 21.83 | 1.24 | 0.82 to 1.80 |
| Immunoproliferative diseases | C88 | 3 | 1.73 | 1.73 | 0.36 to 5.06 |
| Multiple myeloma | C90 | 7 | 9.93 | 0.70 | 0.28 to 1.45 |
| Leukaemia | C91–95 | 22 | 23.42 | 0.94 | 0.59 to 1.42 |
| Lymphoid/haematopoietic tissue | C81–96 | 67 | 60.64 | 1.10 | 0.86 to 1.41 |
| Alcohol-related cancers | * | 38 | 31.77 | 1.20 | 0.85 to 1.64 |
| Low-survival cancers | † | 147 | 135.55 | 1.08 | 0.92 to 1.27 |
| Non-low-survival cancers | ‡ | 635 | 546.75 | 1.16 | 1.07 to 1.26 |
*Tongue (C01–02); mouth (C03–06); pharynx (C09–14); oesophagus (C15); liver (C22) and larynx (C32).
†Oesophagus (C15); stomach (C16); liver (C22); gall bladder and bile ducts (C23–24); pancreas (C25); other digestive organs (C26); lung and trachea (C33–34); heart, mediastinum and pleura (C38); other or unspecified cancer (C39, C76, C80) and mesothelioma (C45).
‡Cancers other than those listed in the footnote (†).
ICD-10, International Classification of Diseases, 10th revision.